https://www.selleckchem.com/pr....oducts/trilaciclib.h
i-institutional trial. Combined modality treatment using HDR prostate brachytherapy leads to excellent long-term clinical outcomes in this prospective multi-institutional trial. Although proton therapy is controversial, it has been used to treat localized prostate cancer over the past 2 decades. The purpose of this study is to examine the long-term efficacy and toxicity of proton therapy for localized prostate cancer. This was a retrospective observational study of 2021 patients from 2003 to 2014 at a single institution. Patients we
Respect!
Kommentar
Delen
